Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-024-03406-8
PubMed Identifier: 39794616
Publication URI: http://europepmc.org/abstract/MED/39794616
Type: Journal Article/Review
Volume: 31
Parent Publication: Nature medicine
Issue: 3
ISSN: 1078-8956